服务热线
Anti-SARS-CoV-2 Spike RBD mAbs [Cilgavimab Biosimilar] (MABL-4523)
Anti-PDCD1/CD279/PD1;CTLA4/CD152 mAbs [Cadonilimab Biosimilar] (MABL-4493)
Anti-CCR8/CKR-L1/CDw198 mAbs [Cafelkibart Biosimilar] (MABL-4494)
Anti-Bacteria Proteins HU and IHF mAbs [Calpurbatug Biosimilar] (MABL-4495)
Anti-ERBB2/CD340/HER2 mAbs [Calotatug Biosimilar] (MABL-4496)
Anti-IL2RA/CD25 mAbs [Camidanlumab Biosimilar] (MABL-4497)
Anti-IL18 mAbs [Camoteskimab Biosimilar] (MABL-4498)
Anti-PDCD1/CD279/PD1 mAbs [Camrelizumab Biosimilar] (MABL-4499)
Anti-IL1B mAbs [Canakinumab Biosimilar] (MABL-4500)
Anti-SARS-CoV-2 RBD mAbs [Canrivitug Biosimilar] (MABL-4501)
Anti-MUC1/PEM/EMA mAbs [Cantuzumab Biosimilar] (MABL-4502)
Anti-VWF mAbs [Caplacizumab Biosimilar] (MABL-4503)
Anti-CCL2/MCP1 mAbs [Carlumab Biosimilar] (MABL-4504)
Anti-ENG/CD105 mAbs [Carotuximab Biosimilar] (MABL-4505)
Anti-IL27 mAbs [Casdozokitug Biosimilar] (MABL-4506)
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn
陕ICP备2021006339号
![Anti-SARS-CoV-2 Spike RBD mAbs [Cilgavimab Biosimilar] (MABL-4523)](/uploads/allimg/2025/11/02/9960ec5c67c9a9cdd85ddeef630a5098.png)
![Anti-PDCD1/CD279/PD1;CTLA4/CD152 mAbs [Cadonilimab Biosimilar] (MABL-4493)](/uploads/allimg/2025/11/02/2eb6aa58b307641a656da38c5278ea7c.png)